Candriam S.C.A. Acquires 16,584 Shares of Mettler-Toledo International, Inc. $MTD

Key Points

• Candriam S.C.A. increased its stake in Mettler-Toledo International by 124.1%, acquiring 16,584 shares to bring its total to 29,948 shares, valued at approximately $35.37 million.
• Mettler-Toledo reported earnings of $10.09 per share, surpassing expectations, and had a revenue of $983.22 million, which was above analyst forecasts.
• Despite strong earnings, several analyst price targets have been revised downward, with an average price target now set at $1,288.89 and ratings varying between "Buy" and "Hold."

Candriam S.C.A. lifted its holdings in shares of Mettler-Toledo International, Inc. (NYSE:MTD - Free Report) by 124.1% in the first quarter, according to its most recent filing with the SEC. The firm owned 29,948 shares of the medical instruments supplier's stock after acquiring an additional 16,584 shares during the period. Candriam S.C.A. owned approximately 0.14% of Mettler-Toledo International worth $35,366,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Farther Finance Advisors LLC lifted its holdings in shares of Mettler-Toledo International by 39.1% during the 1st quarter. Farther Finance Advisors LLC now owns 89 shares of the medical instruments supplier's stock worth $103,000 after acquiring an additional 25 shares during the period. QRG Capital Management Inc. lifted its holdings in Mettler-Toledo International by 29.4% during the 1st quarter. QRG Capital Management Inc. now owns 489 shares of the medical instruments supplier's stock valued at $577,000 after purchasing an additional 111 shares during the last quarter. Mirae Asset Global Investments Co. Ltd. lifted its holdings in Mettler-Toledo International by 13.3% during the 1st quarter. Mirae Asset Global Investments Co. Ltd. now owns 2,488 shares of the medical instruments supplier's stock valued at $2,929,000 after purchasing an additional 292 shares during the last quarter. Wealth Enhancement Advisory Services LLC lifted its position in shares of Mettler-Toledo International by 95.0% during the first quarter. Wealth Enhancement Advisory Services LLC now owns 2,202 shares of the medical instruments supplier's stock worth $2,600,000 after purchasing an additional 1,073 shares in the last quarter. Finally, Boston Trust Walden Corp grew its position in shares of Mettler-Toledo International by 7.1% during the 1st quarter. Boston Trust Walden Corp now owns 34,610 shares of the medical instruments supplier's stock worth $40,871,000 after buying an additional 2,296 shares during the period. 95.07% of the stock is owned by institutional investors.

Mettler-Toledo International Stock Performance

Shares of NYSE MTD opened at $1,323.5850 on Wednesday. The stock has a market cap of $27.27 billion, a P/E ratio of 33.52, a P/E/G ratio of 3.94 and a beta of 1.34. Mettler-Toledo International, Inc. has a 52-week low of $946.69 and a 52-week high of $1,521.01. The firm has a 50 day moving average price of $1,220.14 and a 200 day moving average price of $1,188.83.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last released its quarterly earnings results on Thursday, July 31st. The medical instruments supplier reported $10.09 earnings per share for the quarter, beating the consensus estimate of $9.58 by $0.51. The company had revenue of $983.22 million during the quarter, compared to analysts' expectations of $957.41 million. Mettler-Toledo International had a net margin of 21.46% and a negative return on equity of 476.07%. The business's quarterly revenue was up 3.9% compared to the same quarter last year. During the same quarter in the prior year, the company earned $9.65 earnings per share. Mettler-Toledo International has set its FY 2025 guidance at 42.100-42.600 EPS. Q3 2025 guidance at 10.550-10.750 EPS. Analysts predict that Mettler-Toledo International, Inc. will post 42.71 earnings per share for the current fiscal year.

Insider Buying and Selling at Mettler-Toledo International

In other news, CFO Shawn Vadala sold 300 shares of the business's stock in a transaction on Friday, August 8th. The shares were sold at an average price of $1,254.09, for a total value of $376,227.00. Following the sale, the chief financial officer owned 5,095 shares of the company's stock, valued at $6,389,588.55. The trade was a 5.56% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Thomas P. Salice sold 1,062 shares of the business's stock in a transaction on Wednesday, August 13th. The stock was sold at an average price of $1,300.90, for a total transaction of $1,381,555.80. Following the completion of the sale, the director directly owned 283 shares in the company, valued at approximately $368,154.70. This represents a 78.96% decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders sold 2,589 shares of company stock worth $3,205,554. Company insiders own 0.77% of the company's stock.

Analysts Set New Price Targets

MTD has been the subject of several analyst reports. Wall Street Zen cut shares of Mettler-Toledo International from a "buy" rating to a "hold" rating in a research report on Monday, May 5th. Evercore ISI lowered their price target on shares of Mettler-Toledo International from $1,280.00 to $1,275.00 and set an "outperform" rating for the company in a research report on Monday, August 4th. Bank of America lifted their price target on shares of Mettler-Toledo International from $1,200.00 to $1,260.00 and gave the stock a "neutral" rating in a research report on Thursday, June 26th. UBS Group upgraded shares of Mettler-Toledo International from a "neutral" rating to a "buy" rating and lowered their price target for the stock from $1,530.00 to $1,350.00 in a research report on Tuesday, May 20th. Finally, Wells Fargo & Company lifted their price target on shares of Mettler-Toledo International from $1,125.00 to $1,200.00 and gave the stock an "equal weight" rating in a research report on Monday, May 5th. Five research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company. According to MarketBeat, the company has an average rating of "Moderate Buy" and an average price target of $1,288.89.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.